Japanese
English
- 有料閲覧
PPV購入案内
1,320円 (1,200円+税10%) こちらは、719ページから726ページの文献です。購入には医書.jp本会員登録が必要です。
会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。
会員登録について詳しくはをご確認ください。
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
Point
・STA-MCAバイパス術の適応決定には定量的脳循環代謝検査による評価が必要である.
・指標として,慢性脳虚血の重症度を反映する酸素摂取率,脳血液量,血管反応性などが用いられる.
・15O-PETやアセタゾラミドSPECTが標準であり,CT,MRIの意義は十分確立していない.
The assessment of cerebral perfusion and metabolism is crucial in evaluating the indications for bypass surgery and other revascularization procedures in patients with chronic hemodynamic cerebral ischemia. In particular, it is necessary to detect misery perfusion(Powers' stage Ⅱ), which is defined as an increased oxygen extraction fraction and increased cerebral blood volume or impaired cerebrovascular reactivity, with a constant cerebral metabolic rate of oxygen. Among the imaging techniques available for this purpose, 15O-positron emission tomography(PET)and acetazolamide-challenge single-photon emission computed tomography(SPECT)remain the de facto standards; however, these have substantial limitations such as invasiveness and the risk of severe adverse effects. Recently, several less invasive, easy-to-use techniques, such as perfusion computed tomography and magnetic resonance(MR)imaging, arterial spin labeling, quantitative susceptibility mapping, intravoxel incoherent motion, MR spectroscopy, and single-slab MR angiography, have also been introduced. These techniques may serve as alternatives to PET or SPECT if validation studies are successful and standardization among vendors is achieved.

Copyright © 2022, Igaku-Shoin Ltd. All rights reserved.

